"Immune checkpoint inhibitor therapy-related pneumonitis / immune-mediated pneumonitis usually happens between 8 to 14 weeks after the start of treatment 13. Examples of agents include:"
"interstitial fibrosis: typically NSIP 5 pattern"
"FOLFOX-induced interstitial pneumonia (FIIP) 22"
"ALK inhibitors"
"TNF-alpha blockers: adalimumab-induced interstitial lung disease 16"
Expected headings
"Chemotherapy agents"
"Immunosuppressive agents"
"Immunotherapy agents"
"Monoclonal antibody"
"Disease-modifying antirheumatic drugs (DMARDs)"
"Cardiovascular agents"
"Antibiotic agents"
"Anti-inflammatory agents"
"Non-medical drug use"
"Antiseizure medications"
"Others"